Revolution Medicines, Inc. RVMD
- zoldonrasib — Pancreatic Ductal Adenocarcinoma Phase 3
- zoldonrasib — Non-Small Cell Lung Cancer Phase 3
RAS G12D (1 companies · 2 programs)
Companies with an active program directed at RAS G12D.
Companies with an active program directed at RAS G12D.